Amgen headquarters in Thousand Oaks. (Courtesy photo) Thousand Oaks-based biotech giant Amgen is being sued for allegedly failing to quickly disclose to investors it might owe the Internal Revenue Service more than $10 billion in back taxes and penalties. The class action lawsuit was brought by Detroit-based Roofers Local No. 149 Pension Fund and filed…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
